Filtered By:
Specialty: Cardiology
Condition: Cardiomyopathy
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 533 results found since Jan 2013.
Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly
CONCLUSIONS: Serum FSTL1 levels are not associated with functional and structural measures of myocardium in patients with acromegaly. However, the risk of left ventricular hypertrophy is reduced in CC genotyped individuals of FSTL1.PMID:34233581 | DOI:10.1080/00015385.2021.1948206
Source: Acta Cardiologica - July 8, 2021 Category: Cardiology Authors: Suleyman Nahit Sendur Tuncay Hazirolan Busra Aydin Incilay Lay Mehmet Alikasifoglu Tomris Erbas Source Type: research
Stroke and Bleeding Risk Assessment in Atrial Fibrillation: Where Are We Now?
Korean Circ J. 2021 Jun 1. doi: 10.4070/kcj.2021.0170. Online ahead of print.ABSTRACTMost important international guidelines recommend the use of CHA₂DS₂-VASc and HAS-BLED scores for stroke and bleeding risk assessments in atrial fibrillation (AF) patients, respectively. The 2020 AF guidelines of European Society of Cardiology have revised the definition of "C: congestive heart failure (HF)" component, and now patients with either HF with reduced ejection fraction or preserved ejection fraction should be assigned 1 point. Hypertrophic cardiomyopathy was also included. Besides, the revised "V: vascular diseases" compone...
Source: Korean Circulation Journal - July 6, 2021 Category: Cardiology Authors: Ling Kuo Yi Hsin Chan Jo Nan Liao Shih Ann Chen Tze Fan Chao Source Type: research
